The North America Rat Model Market should witness market growth of 6.3% CAGR during the forecast period (2022-2028).
In recent years, the use of rat models for medical investigation and testing has become more acceptable. These models offer information about the human disease that are not permitted by other models. Moreover, in the case of rats specifically, their unique DNA and physiology have enabled researchers to identify a number of pathophysiological as well as physiological pathways.
In the domains of pharmacology, physiology, nutrition, toxicology, learning, immunology, and behavior, rats have been utilized to address a vast array of scientific problems related to human disorders. In addition, the physiological closeness of the rat and human genetics has increased the use of rat models in scientific research.
In addition, breakthroughs in gene editing as well as gene targeting made possible by the advent of synthetic biology have made it possible to precisely tweak the rat genome in order to generate knock-in and knock-out models. This significantly enhances our understanding of human disease through the development of personalized, potent CRISPR rat models. In addition, these GEM rat models reduce the likelihood of treatment failure during clinical trials.
The regional research and development industry is expanding increasingly. Research and development carried out by businesses based in the United States are referred to as U.S. business R&D. It encompasses all of the R&D that was carried out by the company and was funded by the company on its own (from company-owned, units or from subsidiaries overseas). It also encompasses the research and development activities carried out by the company but funded by third parties, such as other corporations, the federal government of the United States, nonfederal governments (local and the state as well as foreign), and charitable organizations or other organizations.
The US market dominated the North America Rat Model Market by Country in 2021; thereby, achieving a market value of $467.8 million by 2028. The Canada market is experiencing a CAGR of 8.7% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2022-2028).
Based on Technology, the market is segmented into CRISPR/CAS & Others, Nuclear transferase, and Embryonic Stem Cell & Microinjection. Based on Type, the market is segmented into Outbred, Hybrid, Knockout, Inbred, Immunodeficient, and Conditioned. Based on Service, the market is segmented into Breeding, Genetic testing, Cryopreservation, Re-derivation, and Quarantine Depending & Others. Based on Application, the market is segmented into Toxicology, Oncology, Immunology, and Neurology & Others. Based on End-use, the market is segmented into CROs, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Inotiv, Inc., genOway, Janvier Labs, Taconic Biosciences, Inc. (H.I.G. Capital), TransViragen, Inc., Biomedical Research Models, Inc. (Biomere) and Cyagen Biosciences.
In recent years, the use of rat models for medical investigation and testing has become more acceptable. These models offer information about the human disease that are not permitted by other models. Moreover, in the case of rats specifically, their unique DNA and physiology have enabled researchers to identify a number of pathophysiological as well as physiological pathways.
In the domains of pharmacology, physiology, nutrition, toxicology, learning, immunology, and behavior, rats have been utilized to address a vast array of scientific problems related to human disorders. In addition, the physiological closeness of the rat and human genetics has increased the use of rat models in scientific research.
In addition, breakthroughs in gene editing as well as gene targeting made possible by the advent of synthetic biology have made it possible to precisely tweak the rat genome in order to generate knock-in and knock-out models. This significantly enhances our understanding of human disease through the development of personalized, potent CRISPR rat models. In addition, these GEM rat models reduce the likelihood of treatment failure during clinical trials.
The regional research and development industry is expanding increasingly. Research and development carried out by businesses based in the United States are referred to as U.S. business R&D. It encompasses all of the R&D that was carried out by the company and was funded by the company on its own (from company-owned, units or from subsidiaries overseas). It also encompasses the research and development activities carried out by the company but funded by third parties, such as other corporations, the federal government of the United States, nonfederal governments (local and the state as well as foreign), and charitable organizations or other organizations.
The US market dominated the North America Rat Model Market by Country in 2021; thereby, achieving a market value of $467.8 million by 2028. The Canada market is experiencing a CAGR of 8.7% during (2022-2028). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2022-2028).
Based on Technology, the market is segmented into CRISPR/CAS & Others, Nuclear transferase, and Embryonic Stem Cell & Microinjection. Based on Type, the market is segmented into Outbred, Hybrid, Knockout, Inbred, Immunodeficient, and Conditioned. Based on Service, the market is segmented into Breeding, Genetic testing, Cryopreservation, Re-derivation, and Quarantine Depending & Others. Based on Application, the market is segmented into Toxicology, Oncology, Immunology, and Neurology & Others. Based on End-use, the market is segmented into CROs, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Inotiv, Inc., genOway, Janvier Labs, Taconic Biosciences, Inc. (H.I.G. Capital), TransViragen, Inc., Biomedical Research Models, Inc. (Biomere) and Cyagen Biosciences.
Scope of the Study
By Technology
- CRISPR/CAS & Others
- Nuclear transferase
- Embryonic Stem Cell & Microinjection
By Type
- Outbred
- Hybrid
- Knockout
- Inbred
- Immunodeficient
- Conditioned
By Service
- Breeding
- Genetic testing
- Cryopreservation
- Re-derivation
- Quarantine Depending & Others
By Application
- Toxicology
- Oncology
- Immunology
- Neurology & Others
By End-use
- CROs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Charles River Laboratories International, Inc.
- Laboratory Corporation of America Holdings
- Inotiv, Inc.
- genOway
- Janvier Labs
- Taconic Biosciences, Inc. (H.I.G. Capital)
- TransViragen, Inc.
- Biomedical Research Models, Inc. (Biomere)
- Cyagen Biosciences
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Rat Model Market by Technology
Chapter 4. North America Rat Model Market by Type
Chapter 5. North America Rat Model Market by Service
Chapter 6. North America Rat Model Market by Application
Chapter 7. North America Rat Model Market by End-use
Chapter 8. North America Rat Model Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Charles River Laboratories International, Inc.
- Laboratory Corporation of America Holdings
- Inotiv, Inc.
- genOway
- Janvier Labs
- Taconic Biosciences, Inc. (H.I.G. Capital)
- TransViragen, Inc.
- Biomedical Research Models, Inc. (Biomere)
- Cyagen Biosciences
Methodology
LOADING...
